Physician profile
Susan E Mckey
NPI 1386084705
$1,280.55
in general payments reported to CMS, 2019-2025
13 companies · $90.48 in 2025
The $90.48 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $138 · 2021: $177 · 2022: $244 · 2023: $213 · 2024: $171 · 2025: $90.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $331.67 | 2019-2025 | |
| Sanofi Pasteur INC. | $218.86 | 2021-2025 | |
| Glaxosmithkline, LLC. | $216.13 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $181.05 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Baxter Healthcare | $125.00 | 2020 | |
| Depuy Synthes Sales INC. | $62.89 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.86 | 2022 | |
| Sobi, INC | $28.71 | 2019-2020 | |
| Davol INC. | $25.95 | 2024 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $18.46 | 2023 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $16.31 | 2019 | |
| Tris Pharma INC | $12.77 | 2019 | |
| Shire North American Group INC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Mckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.